Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 5455-5459, October 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaffney, E. V.
Right arrow Articles by Lingenfelter, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaffney, E. V.
Right arrow Articles by Lingenfelter, S. E.

Correlation between Human Cell Growth Response to Interleukin 1 and Receptor Binding1

E. V. Gaffney2, G. Koch, S-C. Tsai, T. Loucks and S. E. Lingenfelter

Department of Molecular and Cell Biology, The Pennsylvania State University, University Park, Pennsylvania 16802 [E. V. G., S-C. T., T. L., S. E. L.], and Cistron Biotechnology, Pine Brook, New Jersey 07058 [G. K.]

Human recombinant interleukin 1{alpha} (IL-1{alpha}) and IL-1ß inhibited the replication of the mammary tumor cell line, MDA-MB-415; stimulated division in the colon carcinoma, SW-48; and had no effect on the growth of the milk mammary line, HBL-100. Inhibition of growth was reflected in a significant decrease in DNA synthesis accompanying a transient increase in RNA synthesis. Specific binding of 125I-labeled recombinant IL-1ß by MDA-MB-415 and SW-48 reached a maximum by 2 h of incubation, and an equivalent amount was bound by each cell type. Binding was inhibited in a dose-dependent manner by unlabeled IL-1{alpha} or IL-1ß. Scatchard plot analysis revealed that MDA-MB-415 cells expressed approximately 700 binding sites with an apparent dissociation constant of 8.8 x 10-10 M. Reversibility of growth inhibition was independent of dose or time of incubation, but DNA synthesis did not return to control values. Flow cytometric analysis of DNA content showed that growth inhibition was cell cycle phase nonspecific with a slight reduction in the proportion of cells in S phase. The major conclusion from these studies was that inhibition or stimulation of malignant cell growth by IL-1 was related to the presence of receptor sites.

1 Supported in part by Grants CA 44677 and CA 45143 from the Department of Health and Human Services.

2 To whom requests for reprints should be addressed, at 306 South Frear Building, University Park, PA 16802.

Received 12/29/87. Revised 4/27/88. Revised 6/29/88. Accepted 7/ 6/88.




This article has been cited by other articles:


Home page
BloodHome page
A. Spyridonidis, W. Bernhardt, D. Behringer, G. Kohler, M. Azemar, A. Pflug, and R. Henschler
Proliferation and Survival of Mammary Carcinoma Cells Are Influenced by Culture Conditions Used for Ex Vivo Expansion of CD34+ Blood Progenitor Cells
Blood, January 15, 1999; 93(2): 746 - 755.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.